Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:49 AM
Ignite Modification Date:
2025-12-26 @ 11:49 AM
NCT ID:
NCT01904916
Eligibility Criteria:
Inclusion Criteria:
* Locally advanced (incurable) or metastatic cancer from a histological or cytological proven solid tumor
* Indication for systemic treatment with anti-cancer agents (with no treatment options with curative intent)
* Measurable locally advanced (incurable) or metastatic lesion(s), according to RECIST 1.1 criteria.
* Safe biopsy of a metastatic or locally advanced lesion possible
* No contraindications for lidocaine (or its derivatives) and/or midazolam and/or phentanyl
* Adequate organ function
* WHO performance status 0-2
* Age \> 18 yr
* Expected adequacy to follow up
* Written informed consent
Exclusion Criteria:
• If one or more of the above mentioned inclusion criteria is not met
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01904916
Study Brief:
Protocol Section:
NCT01904916